Eaton Vance National Municipl Opprtnt Tr  

(Public, NYSE:EOT)   Watch this stock  
Find more results for EOT
19.65
-0.02 (-0.12%)
Real-time:   11:30AM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 19.58 - 19.72
52 week 19.38 - 25.30
Open 19.63
Vol / Avg. 27,005.00/65,935.00
Mkt cap 20.00
P/E     -
Div/yield 0.09/5.24
EPS     -
Shares 1.00
Beta -0.10
Inst. own 511416000%

Key stats and ratios

2010
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets - -
Return on average equity - -
Carbon Disclosure Rating - -

Address

Two International Place
BOSTON, MA 02110
United States - Map
+1-617-4828260 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Eaton Vance National Municipal Opportunities Trust (The Trust) is a closed-end fund. The Trust�s primary investment objective is to provide current income exempt from federal income tax. The Trust will, as a secondary investment objective, seek to achieve capital appreciation. The Trust invests primarily in municipal obligations that, at the time of investment, are investment-grade quality. The Trust�s investment manager is Eaton Vance Management (EVM).

Officers and directors

Ralph F. Verni Independent Chairman of the Board of Trustees
Age: 70
Bio & Compensation  - Reuters
Cynthia J. Clemson President
Age: 49
Bio & Compensation  - Reuters
Paul M. O'Neil Chief Compliance Officer
Age: 59
Bio & Compensation  - Reuters
Maureen A. Gemma Vice President, Chief Legal Officer, Secretary
Age: 52
Bio & Compensation  - Reuters
Payson F. Swaffield Vice President
Age: 56
Bio & Compensation  - Reuters
Barbara E. Campbell Treasurer
Age: 55
Bio & Compensation  - Reuters
Scott E. Eston Independent Trustee
Age: 57
Bio & Compensation  - Reuters
Benjamin C. Esty Independent Trustee
Age: 50
Bio & Compensation  - Reuters
Thomas E. Faust Jr. Trustee
Age: 54
Bio & Compensation  - Reuters
Allen R. Freedman Independent Trustee
Age: 72
Bio & Compensation  - Reuters